Tirofiban for Reduction of TEAR: A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial. Hu X, Jiang Q, Wang N, Liu Q, et al. Stroke 2026 Jun 12. doi: 10.1161/STROKEAHA.126.056558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu X, Jiang Q, Wang N, Liu Q, et al. Tirofiban for Reduction of TEAR: A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial. Stroke 2026 Jun 12. doi: 10.1161/STROKEAHA.126.056558.
PMID: 42283072